Taysha Gene Therapies advances pivotal TSHA-102 trial with FDA alignment, strong Q2 performance, and positive clinical data.

The first-time founders of Sun Home Saunas set out to upend a market that was ready for an e-commerce spin up.

Below are the transcripts from the Q2 earnings call. This transcript is brought to you by Benzinga APIs. For real-time access ...